glp-1 market news november 2025 Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP-1 Market Size, Share |

Several patients reported improvements in mood, including patients who felt depressed prior to starting the medication

27 This emphasizes the need for robust and well-designed RCTs with a large population and longer duration to establish the extent of the role of GLP-1RAs in different subpopulations

Not at first, but they eventually relented

Clinicians should be aware of this risk, especially when treating patients with a history of gallbladder disease or those experiencing very rapid weight loss

Behavioral strategies for long-term weight loss maintenance

For individuals whose primary concern is liver health rather than just body weight, retatrutide appears to be dramatically superior